Dr. Volodymyr Deineka, a research fellow at Biomedical Research Center, got a post-doctoral position at the University of Latvia under the MSCA4Ukraine Fellowship. This fellowship scheme was dedicated as part of the EU’s response to the russian federation’s invasion of Ukraine. MSCA4Ukraine grants will enable displaced researchers to continue their work at academic and non-academic organizations in EU Member States and Horizon Europe Associated countries while maintaining their connections to research and innovation communities in Ukraine. The scheme may also facilitate researchers’reintegration in Ukraine if conditions for safe return are met, in order to prevent permanent brain drain and contribute to strengthening the Ukrainian university and research sector and its collaboration and exchange with the international research community.
The “I-NanoTerm” project scope is developing a new effective anticancer treatment strategy based on the targeted PTT effect using MXene nanosheets. This project is inspired by cooperation with Prof. Yury Gogotsi, who discovered a novel class of 2D materials – MXenes. They are a fast-growing family of 2D materials demonstrating major applications in lithium and sodium-ion batteries, electrocatalysts nanomaterials, optoelectronic devices, flexible electronics, and medicine (cancer treatment, bacteriology, immunology, target drug delivery, tissue engineering, etc.). We will use MXenes from Carbone Ukraine (CEO- Alex Gogotsi), the world leader in MX phase and MXene development. Using novel technologies, we are looking to develop a concept of targeting therapy of malignant tumours with minimal side effects.